1. Home
  2. ENTX vs BRCC Comparison

ENTX vs BRCC Comparison

Compare ENTX & BRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

N/A

Current Price

$2.85

Market Cap

147.4M

Sector

Health Care

ML Signal

N/A

Logo BRC Inc.

BRCC

BRC Inc.

N/A

Current Price

$8.93

Market Cap

128.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTX
BRCC
Founded
2010
2014
Country
Israel
United States
Employees
N/A
468
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
128.9M
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
ENTX
BRCC
Price
$2.85
$8.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$9.75
★ $22.50
AVG Volume (30 Days)
★ 389.5K
74.0K
Earning Date
11-13-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.22
N/A
Revenue
$42,000.00
★ $398,263,000.00
Revenue This Year
N/A
$8.52
Revenue Next Year
N/A
$8.04
P/E Ratio
$12.05
★ N/A
Revenue Growth
N/A
★ 1.73
52 Week Low
$0.91
$0.60
52 Week High
$4.20
$10.65

Technical Indicators

Market Signals
Indicator
ENTX
BRCC
Relative Strength Index (RSI) 51.28 63.36
Support Level $2.71 $8.65
Resistance Level $3.12 $10.47
Average True Range (ATR) 0.18 0.47
MACD -0.02 -0.28
Stochastic Oscillator 56.14 23.67

Price Performance

Historical Comparison
ENTX
BRCC

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

Share on Social Networks: